Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A C Roos

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Behavioral Medicine|July 13, 2002
Living with Huntington's disease: illness perceptions, coping mechanisms, and spouses' quality of lifeD I Helder, A A Kaptein, G M J Van Kempen, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatmentD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopaD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
International Clinical Psychopharmacology|March 15, 2002
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reportsI Schillevoort, E P van Puijenbroek, A de Boer, et al.
Acta Neurologica Scandinavica|March 21, 2002
Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa usersD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Journal of Affective Disorders|November 29, 2011
Suicidality in Huntington's diseaseA A M Hubers, N Reedeker, E J Giltay, et al.
Psychosomatics|March 31, 2012
Psychiatric disorders in Huntington's disease: a 2-year follow-up studyW Reedeker, R C van der Mast, E J Giltay, et al.
Journal of Neurology|January 24, 2009
Weight loss in neurodegenerative disordersN A Aziz, M A van der Marck, H Pijl, et al.
European Journal of Neurology|January 14, 2009
Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's diseaseJ C H van Oostrom, M Dekker, A T M Willemsen, et al.
European Journal of Neurology|October 23, 2009
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's diseaseN A Aziz, H Pijl, M Frölich, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Behavioral Medicine|July 13, 2002
Living with Huntington's disease: illness perceptions, coping mechanisms, and spouses' quality of lifeD I Helder, A A Kaptein, G M J Van Kempen, et al.
European Journal of Clinical Pharmacology|May 16, 2002
Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatmentD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
British Journal of Clinical Pharmacology|September 5, 2002
Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopaD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
International Clinical Psychopharmacology|March 15, 2002
Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reportsI Schillevoort, E P van Puijenbroek, A de Boer, et al.
Acta Neurologica Scandinavica|March 21, 2002
Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa usersD A M C van de Vijver, R A C Roos, P A F Jansen, et al.
Journal of Affective Disorders|November 29, 2011
Suicidality in Huntington's diseaseA A M Hubers, N Reedeker, E J Giltay, et al.
Psychosomatics|March 31, 2012
Psychiatric disorders in Huntington's disease: a 2-year follow-up studyW Reedeker, R C van der Mast, E J Giltay, et al.
Journal of Neurology|January 24, 2009
Weight loss in neurodegenerative disordersN A Aziz, M A van der Marck, H Pijl, et al.
European Journal of Neurology|January 14, 2009
Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington's diseaseJ C H van Oostrom, M Dekker, A T M Willemsen, et al.
European Journal of Neurology|October 23, 2009
Growth hormone and ghrelin secretion are associated with clinical severity in Huntington's diseaseN A Aziz, H Pijl, M Frölich, et al.
Pageof 5